Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex in symptomatic endometriosis
NCT00556075Phase 2Terminated
- Sponsor
- Repros Therapeutics Inc.
- Start
- Nov 2007
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of telapristone in endometriosis (3 arms), sponsored by Repros Therapeutics Inc. Primary endpoint: Composite Pain Score at 4 months. Started Nov 2007; status: terminated.
02
Drugs
telapristone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00556075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556075.